Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, hepatologist Giada Sebastiani, MD, discusses why the presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposure to dideoxynucleoside analogues can trigger an evaluation for NAFLD and NASH, particularly in our aging population of patients with HIV with topics including:
Associate Professor of Medicine
McGill University Health Centre
Division of Gastroenterology and Hepatology and Division of Infectious Diseases
Research Institute of McGill University Health Centre
Montreal, Quebec, Canada
This program has been made available online.
Expert insight on the burden and impact of HBV infection, as well as strategies to overcome barriers to vaccination, from Clinical Care Options (CCO)
Podcast describing key aspects of managing NASH in patients with HIV, from Clinical Care Options (CCO)
Podcast describing key strategies to appropriately screen for, identify, and manage NASH in persons with HIV, followed by audience questions, from Clinical Care Options (CCO)
Free slides from CCO featuring data on the prevalence, assessment, and treatment landscape for NASH in people living with HIV.